Panitumumab Beats Bevacizumab in Left-Sided mCRC ...Middle East

The first trial comparing panitumumab or bevacizumab plus standard chemotherapy has shown that the former significantly improves survival in left-sided Ras wild type metastatic colorectal cancer. Medscape Medical News

Hence then, the article about panitumumab beats bevacizumab in left sided mcrc was published today ( Sunday 05/06/2022 - 08:24 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Panitumumab Beats Bevacizumab in Left-Sided mCRC )

Also on site :

• Man arrested on suspicion of fatal shooting in Huntington Beach
• Trump’s letter to Norway proves it: he’s lost his mind over the Nobel Peace Prize
• Trump refuses ‘to think purely of peace’